Portal de Periódicos da CAPES

Consensus on the standardization of terminology in thrombotic thrombocytopenic purpura and related thrombotic microangiopathies

2016; Elsevier BV; Volume: 15; Issue: 2 Linguagem: Inglês

10.1111/jth.13571

1538-7933

Marie Scully, Spero R. Cataland, Paul Coppo, Javier de la Rubia, Kenneth D. Friedman, Johanna A. Kremer Hovinga, Bernhard Lämmle, Masanori Matsumoto, Katerina Pavenski, J. Evan Sadler, Ravi Sarode, Haifeng Wu, Daniel P. Gale, Yoshihiro Fujimura, Vickie McDonald, Flora Peyvandi, I. Scharrer, Agnès Veyradier, John‐Paul Westwood,

Renal Diseases and Glomerulopathies

Unlabelled Box •An international collaboration provides a consensus for clinical definitions. •This concerns thrombotic microangiopathies and thrombotic thrombocytopenic purpura (TTP). •The consensus defines diagnosis, disease monitoring and response to treatment. •Requirements for ADAMTS‐13 are given. Summary Background Thrombotic thrombocytopenic purpura (TTP) and hemolytic–uremic syndrome (HUS) are two important acute conditions to diagnose. Thrombotic microangiopathy (TMA) is a broad pathophysiologic process that leads to microangiopathic hemolytic anemia and thrombocytopenia, and involves capillary and small‐vessel platelet aggregates. The most common cause is disseminated intravascular coagulation, which may be differentiated by abnormal coagulation. Clinically, a number of conditions present with microangiopathic hemolytic anemia and thrombocytopenia, including cancer, infection, transplantation, drug use, autoimmune disease, and pre‐eclampsia and hemolysis, elevated liver enzymes and low platelet count syndrome in pregnancy. Despite overlapping clinical presentations, TTP and HUS have distinct pathophysiologies and treatment pathways. Objectives To present a consensus document from an International Working Group on TTP and associated thrombotic microangiopathies (TMAs). Methods The International Working Group has proposed definitions and terminology based on published information and consensus‐based recommendations. Conclusion The consensus aims to aid clinical decisions, but also future studies and trials, utilizing standardized definitions. It presents a classification of the causes of TMA, and criteria for clinical response, remission and relapse of congenital and immune‐mediated TTP.